Building a durable response to HIV/AIDS: Implications for health systems

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 2, 2011, Pages

  Atun, Rifat ^a,b   Bataringaya, Jacqueline ^a  

^a TUBERCULOSIS AND MALARIA   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; chronic illness; health systems; HIV; sustainability

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIFE EXPECTANCY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SOCIOECONOMICS;

ANTI-HIV AGENTS; COMMUNITY HEALTH PLANNING; DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS;

EID: 79959998987     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182218441     Document Type: Article

References (54)

1. World Health Organization (WHO). Progress on Global Access to HIV Antiretroviral Therapy: A Report on "3 by 5" and Beyond. March 2006. Geneva, Switzerland: WHO; 2006. Available at: http://www.who.int/hiv/ progreport2006-summary-en.pdf. Accessed March 9, 2011.
2. WHO. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2010. Geneva, Switzerland: WHO; 2010.
3. Samb B, Evans T, Atun R, et al, WHO Maximizing Positive Synergies Collaborative Group. An assessment of interactions between global health initiatives and country health systems. Lancet. 2009;373:2137-2169.
4. Yu D, Souteyrand Y, Banda MA, et al. Does investment in HIV/AIDS programs help strengthen health systems in developing countries? Global Health. 2008;4:8.
5. El-Sadr WM, Abrams E. Scale-up of HIV care and treatment: can it transform health care services in resource-limited settings? AIDS. 2007; 21(suppl 5):S65-S70. (Pubitemid 350294909)
6. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505-510. (Pubitemid 44142772)
7. Bartlett JA, Shao JF. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis. 2009;9:637-649.
8. Joint United Nations Program on HIV/AIDS (UNAIDS). UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland: UNAIDS; 2010.
9. Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr. 2010;53:124-130.
10. Atun R, Gurol-Urganci I, McKee M. Health systems and increased longevity in people with HIV and AIDS. BMJ. 2009;338:b2165.
11. Rabkin M, El Sadr W. Why reinvent the wheel? Leveraging the lessons of HIV scale up to confront non-communicable diseases. Global Public Health. 2011;6;247-256.
12. Harries AD, Zachariah R, Jahn A, et al. Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resourcelimited countries. J Acquir Immune Defic Syndr. 2009;52:S14-S16.
13. WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. 2010 Revision. Geneva, Switzerland: WHO; 2010.
14. Konde-Lule J, Makumbi F, Pakker N, et al. Effect of changing antiretroviral treatment eligibility criteria on patient load in Kampala, Uganda. AIDS Care. 2011;23:35-41.
15. Nglazi MD, Lawn SD, Kaplan R, et al. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J Acquir Immune Defic Syndr. 2011;56:e1-e8.
16. Unge C, Sodergard B, Ekstrom AM, et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr. 2009;50:397-402.
17. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
18. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298.
19. Ullrich A, Ott JJ, Vitoria M, et al. Long-term care of AIDS and noncommunicable diseases. Lancet. 2011;377:639-640.
20. Samb B, Desai N, Nishtar S, et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet. 2010;376:1785-1797.
21. Brinkhof MW, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV unrelated mortality. PloS Med. 2009;6:e1000066. Published online April 28, 2009.
22. Floyd S, Molesworth A, Dube A, et al. Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in Northern Malawi. PLoS One. 2010;5:e13499.
23. Reniers G, Araya T, Davey G, et al. Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS. 2009;23:511-518.
24. Herbst AJ, Cooke GS, Barnighausen T, et al. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ. 2009;87:754-762.
25. Tkatchenko-Schmidt E, Atun R, Wall M, et al. Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan. 2010;25:283-291.
26. Atun RA, McKee M, Drobniewski F, et al. Analysis of how health system context influences HIV control: case studies from the Russian Federation. Bull World Health Organ. 2005;83:730-738. (Pubitemid 41474691)
27. Nakanjago D, Kiragga A, Castelnuovo B, et al. Initiating antiretroviral therapy at CD4 counts below 350 cells/ul. What does this mean to HIV/AIDS care programs in Uganda? Presented at: 48th Annual ICAAC/IDSA 46th Annual Meeting; October 25-28, 2008; Washington, DC.
28. Meyer-Rath G, Brennan A, Long L, et al. Total cost and potential cost savings of the national antiretroviral treatment (ART) programme in South Africa 2010 to 2017 [Abstract 16112]. Presented at: 18th International AIDS Conference; July 18-23, 2010; Vienna, Austria.
29. Hallett TB, Gregson S, Dube S, et al. Estimating the resources required in the roll-out of universal access to antiretroviral therapy in Zimbabwe. Cited in: The Treatment Time Bomb. London, United Kingdom: All-Party Parliamentary Treatment Group on AID; 2009.
30. Luetkemeyer AF, Havlir DV, Currier JS. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010;18:57-65.
31. The ART Cohort Collaboration. Causes of death. Clin Infect Dis. 2010;50: 1387-1396.
32. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.
33. Blanco JR, Caro AM, Pérez-Cachafeiro S, et al. HIV infection and aging. AIDS Rev. 2010;12:218-230.
34. Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43: 27-34. (Pubitemid 44306484)
35. Lazarus JV, Nielsen KK. HIVand people over 50 years old in Europe. HIV Med. 2010;11:479-481.
36. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88:847-853.
37. Gulick RM. Antiretroviral treatment 2010: progress and controversies. J Acquir Immune Defic Syndr. 2010;55(suppl 1):S43-S48.
38. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376:49-62.
39. Kitahata MM, Tegger MK, et al. Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002;325:954-957. (Pubitemid 35265216)
40. Mayosi BM, Flisher AJ, Lalloo UG, et al. The burden of noncommunicable diseases in South Africa. Lancet. 2009;374:934-947.
41. Loubiere S, Boyer S, Protopopescu C, et al. Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy. 2009;92:165-173.
42. Atun R, de Jongh T, Secci FV, et al. Integration of targeted health interventions into health systems: a conceptual framework for analysis. Health Policy Plan. 2010;25:104-111.
43. Rabkin M, El-Sadr W, De Cock KM. The impact of HIV scale-up on health systems: a priority research agenda. J Acquir Immune Defic Syndr. 2009;52(suppl 1):S6-S11.
44. Handford C, Tynan A-M, Rackal JM, et al. Setting and organization of care for persons living with HIV/AIDS. Cochrane Database Syst Rev. 2006;3:CD004348.
45. Mutevedzi PC, Lessells RJ, Heller T, et al. Scale up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88: 593-600.
46. Travis P, Bennett S, Haines A, et al. Overcoming health-system constraints to achieve the millennium development goals. Lancet. 2004;364:900-906. (Pubitemid 39221069)
47. Atun R, de Jongh T, Secci F, et al. A systematic review of the evidence on integration of targeted health interventions into health systems. Health Policy Plan. 2010;25:1-14.
48. Atun RA, Bennett S, Duran A. When Do Vertical (Stand-Alone) Programmes Have a Place in Health Systems? Policy Brief. Copenhagen, Denmark: WHO Regional Office for Europe; 2008.
49. DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised noninferiority trial. Lancet. 2010;375:123-131.
50. Buscher AL, Giordano TP. Gaps in knowledge in caring for HIV survivors long-term. JAMA. 2010;304:340-341.
51. Harries AD, Zachariah R, Lawn SD, et al. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(suppl 1):70-75.
52. Marseille E, Dandona L, Marsall N, et al. HIV prevention costs and program scale: data from PANCEA project in five low and middle income countries. BMC Health Serv Res. 2007;7:108.
53. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Intl Health. 2008;13:1005-1015.
54. UNAIDS. Impact of the global financial and economic crisis on the AIDS response. UNAIDS/PCB(25)/09.26. Available at: http://data.unaids.org/pub/ InformationNote/2009/20091030-impact-economic-crisis-on-hiv- final-en.pdf. Accessed April 20, 2011.